News & Upcoming Events

 

ASM Microbe 2019 InDevR will be present at the ASM conference in San Francisco in June. Rose Nash will be offering a presentation, "Assessment of the Correlation between Alternative Influenza ...
Read More
510(k) Market Clearance for FluChip-8G Influenza A+B Assay InDevR receives 510(k) market clearance for the first influenza diagnostic assay capable of distinguishing between seasonal and non-seasonal influenza A subtypes ...
Read More
InDevR Chosen for NIH’s Innovation Zone at BIO International Convention One of select group of NIH SBIR awardees to be featured at BIO   BOULDER COLORADO (4/9/19) — ...
Read More
[Press Release] New VaxArray Neuraminidase Potency Test for N9 InDevR launches first-in-class reagent kit for rapid quantification of N9 in  “pandemic” influenza vaccines.   BOULDER COLORADO (3/26/19) — InDevR ...
Read More
New npj Vaccines Paper on Influenza Neuraminidase Potency Open Full Publication   ...
Read More
VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines ...
Read More